Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases
Programme note: RFA-FD-25-020, R01
FDA Office of Orphan Products Development
Shared attributes
- Jurisdiction: United States
- Funding type: Grant
- Area: Rare disease
Programme recordUS-FDA-OPD-NH
Funding Atlas programme
Efficient and Innovative Natural History Studies in Rare Diseases
Programme note: RFA-FD-25-017
FDA Office of Orphan Products Development
Funding typeGrantJurisdictionUnited StatesAreasRare disease
Documented facts
Key facts
- Funder
- FDA Office of Orphan Products Development
- Programme
- Efficient and Innovative Natural History Studies in Rare Diseases
- Programme note
- RFA-FD-25-017
- Jurisdiction
- United States
- Funding type
- Grant
- Therapeutic areas
- Rare disease
Source-bound timeline
Supplied dates
These dates were recorded in the Atlas as of 3 October 2026. Confirm current timing with the funder.
- Receipt Date (new applications and resubmissions)